COGT Cogent Biosciences, Inc.
Healthcare$32.67+0.28%ClosedMarket Cap: $5.58B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$50.00
Target (Median)
$52.00
Target Range
$35.00 - $60.00
Upside from current price: 53.0%
Rating Distribution
2 Strong Buy9 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-17 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-18 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-01-21 | Wedbush | maintain | Outperform | Outperform |
| 2026-01-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-19 | JP Morgan | maintain | Overweight | Overweight |
| 2025-12-08 | Needham | maintain | Hold | Hold |
| 2025-11-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-11 | Baird | maintain | Neutral | Neutral |
| 2025-11-10 | Leerink Partners | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.77 | $348.3M | 8 |
| Sun Dec 31 | $0.87 | $768.0M | 8 |
| Mon Dec 31 | $2.88 | $1.34B | 6 |
| Tue Dec 31 | $4.36 | $1.73B | 6 |